Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

Clinical trial NCT07654283 · RECRUITING

Trial details

NCT number: NCT07654283
Sponsor: AusperBio Therapeutics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2026-08-04
Primary completion: 2027-05-11
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.